Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
about
Lower blood glucose and variability are associated with earlier recovery from renal injury caused by episodic urinary tract infection in advanced type 2 diabetic chronic kidney disease.CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-scorLack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetesThe clinical utility of C-peptide measurement in the care of patients with diabetesResidual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitusStress and A1c Among People with Diabetes Across the Lifespan.Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial.Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes.
P2860
Q34258750-A2B5FECE-7F70-4889-A781-472C3C7CDA4EQ35561483-A786E3C1-BE70-4059-BC33-FAA4E9ED8489Q35630711-79BEE266-3BB5-465B-837A-A9B2F901AC84Q36361403-EEFA468E-A92A-4506-9151-E848104E9C61Q36868102-AE130EDF-D2BD-42A1-9030-D348D6736E0AQ37108880-05FBAB0B-BB46-47C2-85DD-FD2F0013B0A9Q37278130-DFB73054-D59F-4BC1-B1F4-BC15A1E762D1Q37381456-54650E78-E06F-4A17-98C5-810DD6958AC5Q38861472-BED63AEC-90EE-44EA-B747-868D63D30C7FQ41259339-DDB718CB-B843-437F-A827-645B4C716CA0Q51287734-A2A49391-BE62-4A9B-92F2-D671F98A6AD1Q55451980-EE44B0A5-1CAB-448F-B369-018EEA88D4E1
P2860
Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Achievement of target A1C leve ...... and residual β-cell function.
@ast
Achievement of target A1C leve ...... and residual β-cell function.
@en
type
label
Achievement of target A1C leve ...... and residual β-cell function.
@ast
Achievement of target A1C leve ...... and residual β-cell function.
@en
prefLabel
Achievement of target A1C leve ...... and residual β-cell function.
@ast
Achievement of target A1C leve ...... and residual β-cell function.
@en
P2093
P2860
P50
P356
P1433
P1476
Achievement of target A1C leve ...... and residual β-cell function.
@en
P2093
Ana Maria Arbelaez
Bruce Buckingham
Dongyuan Xing
Neil H White
Nelly Mauras
Roy W Beck
P2860
P304
P356
10.2337/DC11-2190
P407
P50
P577
2012-02-08T00:00:00Z